Invention Grant
US08691804B2 Azetidines and cyclobutanes as histamine H3 receptor antagonists
有权
氮杂环丁烷和环丁烷作为组胺H3受体拮抗剂
- Patent Title: Azetidines and cyclobutanes as histamine H3 receptor antagonists
- Patent Title (中): 氮杂环丁烷和环丁烷作为组胺H3受体拮抗剂
-
Application No.: US12991225Application Date: 2009-05-05
-
Publication No.: US08691804B2Publication Date: 2014-04-08
- Inventor: Adam James Davenport , David James Hallett , Massimo Corsi
- Applicant: Adam James Davenport , David James Hallett , Massimo Corsi
- Applicant Address: DE Hamburg
- Assignee: Evotec AG
- Current Assignee: Evotec AG
- Current Assignee Address: DE Hamburg
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: EP08155915 20080508
- International Application: PCT/EP2009/055418 WO 20090505
- International Announcement: WO2009/135842 WO 20091112
- Main IPC: A01N31/00
- IPC: A01N31/00 ; C07D243/08 ; C07D403/00
Abstract:
The invention relates to compounds of formula (I) wherein R, R0, R1, m, n and X1 to X4 have the meaning as cited in the description and the claims. These compounds are useful as Histamine H3 receptor antagonists. The invention also relates to pharmaceutical compositions, the preparation of such compounds as well as the production and use as medicament.
Public/Granted literature
- US20110105459A1 AZETIDINES AND CYCLOBUTANES AS HISTAMINE H3 RECEPTOR ANTAGONISTS Public/Granted day:2011-05-05
Information query
